5-(4-(2-(5-Ethylpyridin-2-yl)-2-oxoethoxy)benzyl)thiazolidine-2,4-dione

CAS: 146062-49-9

Ref. 3D-WFA06249

Produktinformation

• Name: 5-(4-(2-(5-Ethylpyridin-2-yl)-2-oxoethoxy)benzyl)thiazolidine-2,4-dione
• Synonyme: 5-[[4-[2-(5-Ethyl-2-pyridinyl)-2-oxoethoxy]phenyl]methyl]-2,4-thiazolidinedione, 2,4-Thiazolidinedione, 5-[[4-[2-(5-ethyl-2-pyridinyl)-2-oxoethoxy]phenyl]methyl]-, MSDC 0160, Mitoglitazone, CAY 10415

Beschreibung

5-(4-(2-(5-Ethylpyridin-2-yl)-2-oxoethoxy)benzyl)thiazolidine-2,4-dione (5EPC) is a drug that inhibits tumor growth and has been used for the treatment of diabetes. It is an antidiabetic agent that binds to the receptor of soluble guanylate cyclase, which is responsible for regulating the production of cyclic guanosine monophosphate (cGMP). 5EPC has shown inhibitory effects on chronic kidney disease in patients who are not diabetic. Furthermore, it has been shown that 5EPC can be used in combination with dpp-iv inhibitors for the treatment of metabolic disorders.

• Marke: Biosynth

Chemische Eigenschaften

• Molekulargewicht: 370.43 g/mol
• Formel: C₁₉H₁₈N₂O₄S
• Reinheit: Min. 95%